{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:27:47Z","timestamp":1760711267197},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prim. Care Companion CNS Disord."],"DOI":"10.4088\/pcc.22nr03473","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:18:40Z","timestamp":1698657520000},"source":"Crossref","is-referenced-by-count":6,"title":["The Appearance of Xylazine in the United States as a Fentanyl Adulterant"],"prefix":"10.4088","volume":"25","author":[{"given":"Caitlin E.","family":"Leconte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopa","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2558","published-online":{"date-parts":[[2023,10,31]]},"container-title":["The Primary Care Companion For CNS Disorders"],"original-title":[],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:18:43Z","timestamp":1698657523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/pcc\/appearance-xylazine-united-states-fentanyl-adulterant\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,31]]}},"URL":"https:\/\/doi.org\/10.4088\/pcc.22nr03473","relation":{},"ISSN":["2155-7780"],"issn-type":[{"value":"2155-7780","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}